Exact Therapeutics AS (OSL:EXTX) Debt-to-Asset : 0.02 (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Exact Therapeutics AS Debt-to-Asset?

Exact Therapeutics AS's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.55 Mil. Exact Therapeutics AS's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was kr0.65 Mil. Exact Therapeutics AS's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was kr61.32 Mil. Exact Therapeutics AS's debt to asset for the quarter that ended in Dec. 2023 was 0.02.

Exact Therapeutics AS Debt-to-Asset Historical Data

The historical data trend for Exact Therapeutics AS's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Exact Therapeutics AS Debt-to-Asset Chart

Exact Therapeutics AS Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Asset

Get a 7-Day Free Trial

0.02

Exact Therapeutics AS Semi-Annual Data
	Dec17	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial						0.02	0.02	0.02	0.03	0.02

Competitive Comparison of Exact Therapeutics AS's Debt-to-Asset

For the Biotechnology subindustry, Exact Therapeutics AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Exact Therapeutics AS's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Exact Therapeutics AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Exact Therapeutics AS's Debt-to-Asset falls into.

Exact Therapeutics AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Exact Therapeutics AS's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.546	+	0.65)	/	61.319
	=	0.02

Exact Therapeutics AS's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.546	+	0.65)	/	61.319
	=	0.02

Exact Therapeutics AS (OSL:EXTX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Exact Therapeutics AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Exact Therapeutics AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Exact Therapeutics AS (OSL:EXTX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Exact Therapeutics AS (OSL:EXTX) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ostre Aker vei 19, Oslo, NOR, 0581

Website

https://www.exact-tx.com

Exact Therapeutics AS is a clinical-stage biotechnology company. It is developing a technology platform for therapeutic enhancement - Acoustic Cluster Therapy (ACT). ACT sonoporation is an approach to ultrasound-mediated, targeted drug enhancement that will amplify the clinical utility of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.

Exact Therapeutics AS (OSL:EXTX) Headlines

No Headlines